Data show that in 2015, the size of my country's children's drug market exceeded 120 billion yuan. In 2016, the number of newborns reached an extremely high level in the past 15 years, and the total number of children remained between 220 million and 250 million.In recent years, the growth rate of China's children's drug market has remained above 15%, and the overall average growth rate of the pharmaceutical industry in Yuangao . Pediatric medicine market has great potential According to relevant data, children's medicine has always been a prominent shortcoming in my country's pharmaceutical field. Of the more than 4,500 pharmaceutical factories in China, there are only 30 enterprises with research and development and production capacity for children's medicine, and those that focus on research and development and production of children's medicine are even more. According to the data of the 2016 White Paper on Children\u2019s Drug Safety Survey, the adverse drug reaction rate of children in China is twice that of adults, and the adverse drug reaction rate of newborns is 4 times that of adults. Improper medication causes about 30,000 children in China to hear each year. Damaged. '2015 Children's Medication Safety Report' shows that the proportion of children with drug poisoning has increased from 53% in 2012 to 73% in 2014. Children's medicine has always been in a state of shortage, mainly due to many factors such as difficulty in research and development, unclear pricing advantages, and difficulty in marketing.\u3000It is worth Syringe Blister Packaging Machine Manufacturers that in order to improve the problem of children's medication, the state has continued to provide policy support for the evaluation of children's drug research and development in recent years. For example, in 2012, the State Council's Notice on Printing and Distributing National Drug Safety \u201cTwelfth Five-Year Plan\u201d clearly stated that children should be encouraged to develop suitable dosage forms; in 2013, the State Food and Drug Administration will deepen the reform of drug review and approval to further encourage drug innovation 'Opinions' proposes to encourage the development of medicines for children and strengthen the administration of medicines for children. Recently, in the newly revised 'Drug Management Law' that will be officially implemented from December 1, 'Children's medicine' will be written into the regulations, which clarifies that the country will take effective measures to encourage the development and innovation of children's medicines ,Support the development of new varieties, dosage forms and specifications of children's medicines that meet the physiological characteristics of children, and give priority to review and approval of children's medicines. Industry insiders pointed out that the new version of the 'Drug Management Law' promotes the use of children's medicines to the legal level, and encourages the development and innovation of children's medicines as a separate clause, which provides a legal basis for the next step to encourage children's drug policy formulation and implementation.